Kinetic, Thermodynamic, and Structural Characterizations of the Association between Nrf2-DLGex Degron and Keap1

REFERENCES

• Motohashi H, O'Connor T, Katsuoka F, Engel JD, Yamamoto M. 2002. Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors. Gene 294:1–12. http://dx.doi.org/10.1016/S0378-1119(02)00788-6.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Yamamoto M. 2006. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv. Enzyme Regul. 46:113–140. http://dx.doi.org/10.1016/j.advenzreg.2006.01.007.
   PubMedGoogle Scholar
• Taguchi K, Motohashi H, Yamamoto M. 2011. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16:123–140. http://dx.doi.org/10.1111/j.1365-2443.2010.01473.x.
   PubMed Web of Science ®Google Scholar
• Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M. 1999. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13:76–86.
   PubMed Web of Science ®Google Scholar
• Tong KI, Kobayashi A, Katsuoka F, Yamamoto M. 2006. Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol. Chem. 387:1311–1320.
   PubMed Web of Science ®Google Scholar
• Kobayashi A, Kang MI, Okawa H, Ohtsuji M, Zenke Y, Chiba T, Igarashi K, Yamamoto M. 2004. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24:7130–7139. http://dx.doi.org/10.1128/MCB.24.16.7130-7139.2004.
   PubMed Web of Science ®Google Scholar
• Katoh Y, Iida K, Kang MI, Kobayashi A, Mizukami M, Tong KI, McMahon M, Hayes JD, Itoh K, Yamamoto M. 2005. Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome. Arch. Biochem. Biophys. 433:342–350. http://dx.doi.org/10.1016/j.abb.2004.10.012.
   PubMed Web of Science ®Google Scholar
• McMahon M, Thomas N, Itoh K, Yamamoto M, Hayes JD. 2004. Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron. J. Biol. Chem. 279:31556–31567. http://dx.doi.org/10.1074/jbc.M403061200.
   PubMed Web of Science ®Google Scholar
• Tong KI, Padmanabhan B, Kobayashi A, Shang C, Hirotsu Y, Yokoyama S, Yamamoto M. 2007. Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response. Mol. Cell. Biol. 27:7511–7521. http://dx.doi.org/10.1128/MCB.00753-07.
   PubMed Web of Science ®Google Scholar
• Tong KI, Katoh Y, Kusunoki H, Itoh K, Tanaka T, Yamamoto M. 2006. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol. Cell. Biol. 26:2887–2900. http://dx.doi.org/10.1128/MCB.26.8.2887-2900.2006.
   PubMed Web of Science ®Google Scholar
• Ogura T, Tong KI, Mio K, Maruyama Y, Kurokawa H, Sato C, Yamamoto M. 2010. Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains. Proc. Natl. Acad. Sci. U. S. A. 107:2842–2847. http://dx.doi.org/10.1073/pnas.0914036107.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Shibata T, Takaya K, Shiraishi K, Kohno T, Kunitoh H, Tsuta K, Furuta K, Goto K, Hosoda F, Sakamoto H, Motohashi H, Yamamoto M. 2013. Regulatory nexus of synthesis and degradation deciphers cellular Nrf2 expression levels. Mol. Cell. Biol. 33:2402–2412. http://dx.doi.org/10.1128/MCB.00065-13.
   PubMed Web of Science ®Google Scholar
• Uruno A, Furusawa Y, Yagishita Y, Fukutomi T, Muramatsu H, Negishi T, Sugawara A, Kensler TW, Yamamoto M. 2013. The Keap1-Nrf2 system prevents onset of diabetes mellitus. Mol. Cell. Biol. 33:2996–3010. http://dx.doi.org/10.1128/MCB.00225-13.
   PubMed Web of Science ®Google Scholar
• Joshi G, Johnson JA. 2012. The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases. Recent Pat. CNS Drug Discov. 7:218–229. http://dx.doi.org/10.2174/157488912803252023.
   PubMedGoogle Scholar
• Ramos-Gomez M, Dolan PM, Itoh K, Yamamoto M, Kensler TW. 2003. Interactive effects of nrf2 genotype and oltipraz on benzo[a]pyrene-DNA adducts and tumor yield in mice. Carcinogenesis 24:461–467. http://dx.doi.org/10.1093/carcin/24.3.461.
   PubMed Web of Science ®Google Scholar
• Iida K, Itoh K, Kumagai Y, Oyasu R, Hattori K, Kawai K, Shimazui T, Akaza H, Yamamoto M. 2004. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Cancer Res. 64:6424–6431. http://dx.doi.org/10.1158/0008-5472.CAN-04-1906.
   PubMed Web of Science ®Google Scholar
• Satoh H, Moriguchi T, Takai J, Ebina M, Yamamoto M. 2013. Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis. Cancer Res. 73:4158–4168. http://dx.doi.org/10.1158/0008-5472.CAN-12-4499.
   PubMed Web of Science ®Google Scholar
• Ohkoshi A, Suzuki T, Ono M, Kobayashi T, Yamamoto M. 2013. Role of Keap1-Nrf2 system in upper aerodigestive tract carcinogenesis. Cancer Prev. Res. 6:149–159. http://dx.doi.org/10.1158/1940-6207.CAPR-12-0401-T.
   PubMed Web of Science ®Google Scholar
• Shibata T, Ohta T, Tong KI, Kokubu A, Odogawa R, Tsuta K, Asamura H, Yamamoto M, Hirohashi S. 2008. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc. Natl. Acad. Sci. U. S. A. 105:13568–13573. http://dx.doi.org/10.1073/pnas.0806268105.
   PubMed Web of Science ®Google Scholar
• Singh A, Bodas M, Wakabayashi N, Bunz F, Biswal S. 2010. Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance. Antioxid. Redox Signal. 13:1627–1637. http://dx.doi.org/10.1089/ars.2010.3219.
   PubMed Web of Science ®Google Scholar
• Zhang P, Singh A, Yegnasubramanian S, Esopi D, Kombairaju P, Bodas M, Wu H, Bova SG, Biswal S. 2010. Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth. Mol. Cancer Ther. 9:336–346. http://dx.doi.org/10.1158/1535-7163.MCT-09-0589.
   PubMed Web of Science ®Google Scholar
• Shibata T, Kokubu A, Saito S, Narisawa-Saito M, Sasaki H, Aoyagi K, Yoshimatsu Y, Tachimori Y, Kushima R, Kiyono T, Yamamoto M. 2011. NRF2 Mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer. Neoplasia 13:864–873. http://dx.doi.org/10.1593/neo.11750.
   PubMed Web of Science ®Google Scholar
• Sasaki H, Hikosaka Y, Okuda K, Kawano O, Moriyama S, Yano M, Fujii Y. 2010. NFE2L2 gene mutation in male Japanese squamous cell carcinoma of the lung. J. Thorac. Oncol. 5:786–789. http://dx.doi.org/10.1097/JTO.0b013e3181db3dd3.
   PubMedGoogle Scholar
• Takahashi T, Sonobe M, Menju T, Nakayama E, Mino N, Iwakiri S, Nagai S, Sato K, Miyahara R, Okubo K, Hirata T, Date H, Wada H. 2010. Mutations in Keap1 are a potential prognostic factor in resected non-small cell lung cancer. J. Surg. Oncol. 101:500–506. http://dx.doi.org/10.1002/jso.21520.
   PubMed Web of Science ®Google Scholar
• Inoue D, Suzuki T, Mitsuishi Y, Miki Y, Suzuki S, Sugawara S, Watanabe M, Sakurada A, Endo C, Uruno A, Sasano H, Nakagawa T, Satoh K, Tanaka N, Kubo H, Motohashi H, Yamamoto M. 2012. Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer Sci. 103:760–766. http://dx.doi.org/10.1111/j.1349-7006.2012.02216.x.
   PubMed Web of Science ®Google Scholar
• Ichimura Y, Waguri S, Sou YS, Kageyama S, Hasegawa J, Ishimura R, Saito T, Yang Y, Kouno T, Fukutomi T, Hoshii T, Hirao A, Takagi K, Mizushima T, Motohashi H, Lee MS, Yoshimori T, Tanaka K, Yamamoto M, Komatsu M. 2013. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol. Cell 51:618–631. http://dx.doi.org/10.1016/j.molcel.2013.08.003.
   PubMed Web of Science ®Google Scholar
• Otwinowski Z, Minor W. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307–326. http://dx.doi.org/10.1016/S0076-6879(97)76066-X.
   PubMed Web of Science ®Google Scholar
• Vagin A, Teplyakov A. 2010. Molecular replacement with MOLREP. Acta Crystallogr. D Biol. Crystallogr. 66:22–25. http://dx.doi.org/10.1107/S0907444909042589.
   PubMed Web of Science ®Google Scholar
• Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60:2126–2132. http://dx.doi.org/10.1107/S0907444904019158.
   PubMed Web of Science ®Google Scholar
• Murshudov GN, Vagin AA, Dodson EJ. 1997. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53:240–255. http://dx.doi.org/10.1107/S0907444996012255.
   PubMed Web of Science ®Google Scholar
• Adams PD, Afonine PV, Bunkóczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. 2010. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66:213–221. http://dx.doi.org/10.1107/S0907444909052925.
   PubMed Web of Science ®Google Scholar
• Hu Y, Ju Y, Lin D, Wang Z, Huang Y, Zhang S, Wu C, Jiao S. 2012. Mutation of the Nrf2 gene in non-small cell lung cancer. Mol. Biol. Rep. 39:4743–4747. http://dx.doi.org/10.1007/s11033-011-1266-4.
   PubMedGoogle Scholar
• Cho HY. 2013. Genomic structure and variation of nuclear factor (erythroid-derived 2)-like 2. Oxid. Med. Cell. Longev. 2013:286524. http://dx.doi.org/10.1155/2013/286524.
   PubMed Web of Science ®Google Scholar
• Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, Teague JW, Campbell PJ, Stratton MR, Futreal PA. 2011. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 39:D945–D950. http://dx.doi.org/10.1093/nar/gkq929.
   PubMed Web of Science ®Google Scholar
• Niesen FH, Berglund H, Vedadi M. 2007. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat. Protoc. 2:2212–2221. http://dx.doi.org/10.1038/nprot.2007.321.
   PubMed Web of Science ®Google Scholar
• Leavitt S, Freire E. 2001. Direct measurement of protein binding energetics by isothermal titration calorimetry. Curr. Opin. Struct. Biol. 11:560–566. http://dx.doi.org/10.1016/S0959-440X(00)00248-7.
   PubMed Web of Science ®Google Scholar
• Huang HC, Nguyen T, Pickett CB. 2002. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem. 277:42769–42774. http://dx.doi.org/10.1074/jbc.M206911200.
   PubMed Web of Science ®Google Scholar
• Huang HC, Nguyen T, Pickett CB. 2000. Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. Proc. Natl. Acad. Sci. U. S. A. 97:12475–12480. http://dx.doi.org/10.1073/pnas.220418997.
   PubMed Web of Science ®Google Scholar
• Bloom DA, Jaiswal AK. 2003. Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J. Biol. Chem. 278:44675–44682. http://dx.doi.org/10.1074/jbc.M307633200.
   PubMed Web of Science ®Google Scholar
• Niture SK, Jain AK, Jaiswal AK. 2009. Antioxidant-induced modification of INrf2 cysteine 151 and PKC-δ-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance. J. Cell Sci. 122:4452–4464. http://dx.doi.org/10.1242/jcs.058537.
   PubMed Web of Science ®Google Scholar
• Padmanabhan B, Tong KI, Kobayashi A, Yamamoto M, Yokoyama S. 2008. Structural insights into the similar modes of Nrf2 transcription factor recognition by the cytoplasmic repressor Keap1. J. Synchrotron Radiat. 15:273–276. http://dx.doi.org/10.1107/S090904950705114X.
   PubMedGoogle Scholar
• Padmanabhan B, Tong KI, Ohta T, Nakamura Y, Scharlock M, Ohtsuji M, Kang MI, Kobayashi A, Yokoyama S, Yamamoto M. 2006. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol. Cell 21:689–700. http://dx.doi.org/10.1016/j.molcel.2006.01.013.
   PubMed Web of Science ®Google Scholar
• Fujii S, Sawa T, Ihara H, Tong KI, Ida T, Okamoto T, Ahtesham AK, Ishima Y, Motohashi H, Yamamoto M, Akaike T. 2010. The critical role of nitric oxide signaling, via protein S-guanylation and nitrated cyclic GMP, in the antioxidant adaptive response. J. Bol. Chem. 285:23970–23984. http://dx.doi.org/10.1074/jbc.M110.145441.
   PubMed Web of Science ®Google Scholar
• Karlsson R, Fält A. 1997. Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. J. Immunol. Methods 200:121–133. http://dx.doi.org/10.1016/S0022-1759(96)00195-0.
   PubMed Web of Science ®Google Scholar
• Lipschultz CA, Li Y, Smith-Gill S. 2000. Experimental design for analysis of complex kinetics using surface plasmon resonance. Methods 20:310–318. http://dx.doi.org/10.1006/meth.1999.0924.
   PubMed Web of Science ®Google Scholar
• Chen Y, Inoyama D, Kong AN, Beamer LJ, Hu L. 2011. Kinetic analyses of Keap1-Nrf2 interaction and determination of the minimal Nrf2 peptide sequence required for Keap1 binding using surface plasmon resonance. Chem. Biol. Drug Des. 78:1014–1021. http://dx.doi.org/10.1111/j.1747-0285.2011.01240.x.
   PubMedGoogle Scholar
• McMahon M, Thomas N, Itoh K, Yamamoto M, Hayes JD. 2006. Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a “tethering” mechanism: a two-site interaction model for the Nrf2-Keap1 complex. J. Biol. Chem. 281:24756–24768. http://dx.doi.org/10.1074/jbc.M601119200.
   PubMed Web of Science ®Google Scholar
• Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y, Sou YS, Ueno I, Sakamoto A, Tong KI, Kim M, Nishito Y, Iemura S, Natsume T, Ueno T, Kominami E, Motohashi H, Tanaka K, Yamamoto M. 2010. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat. Cell Biol. 12:213–223. http://dx.doi.org/10.1038/ncb2021.
   PubMed Web of Science ®Google Scholar
• Baird L, Llères D, Swift S, Dinkova-Kostova AT. 2013. Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex. Proc. Natl. Acad. Sci. U. S. A. 110:15259–15264. http://dx.doi.org/10.1073/pnas.1305687110.
   PubMed Web of Science ®Google Scholar